Gene · 6385
Papers3,062
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,062
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acquired ROS1 fusion and iruplinalkib response in advanced NSCLC after multiple lines of systematic therapy: a case report. | Front Oncol | 2025 | 40371229 | PubTator, text mining | PubMed |
| Decoding ARF4 and EIF5B-Based Prognostic Signatures and Immune Landscape Following Insufficient Radiofrequency Ablation in Hepatocellular Carcinoma: Through Multi-Omics and Experimental Validation. | J Hepatocell Carcinoma | 2025 | 40370639 | PubTator, text mining | PubMed |
| SDC4 identified as an oncogenic target gene of NF-κB in TNFα-Induced tumor cells. | Sci Rep | 2025 | 40341546 | PubTator, text mining | PubMed |
| scSDNE: A semi-supervised method for inferring cell-cell interactions based on graph embedding. | PLoS Comput Biol | 2025 | 40333631 | PubTator, text mining | PubMed |
| Harnessing agent-based frameworks in CellAgentChat to unravel cell-cell interactions from single-cell and spatial transcriptomics. | Genome Res | 2025 | 40316422 | PubTator, text mining | PubMed |
| 1,4-Dioxane Induces Epithelial-Mesenchymal Transition and Carcinogenesis in an Nrf2-Dependent Manner. | J Extracell Vesicles | 2025 | 40304624 | PubTator, text mining | PubMed |
| COL1A1-positive endothelial cells promote gastric cancer progression via the ANGPTL4-SDC4 axis driven by endothelial-to-mesenchymal transition. | Cancer Lett | 2025 | 40254092 | PubTator, text mining | PubMed |
| The Ceramide-Dependent EV Secretome Differentially Affects Prostate Cancer Cell Migration. | Cells | 2025 | 40214501 | PubTator, text mining | PubMed |
| Syndecans and glycosaminoglycans influence B-cell development and activation. | EMBO Rep | 2025 | 40155751 | PubTator, text mining | PubMed |
| Glypican3 and serglycin as potential biomarkers involved in the pathogenesis of ovarian endometriosis. | Tissue Cell | 2025 | 40139079 | PubTator, text mining | PubMed |
| Trastuzumab Decreases the Expression of G1/S Regulators and Syndecan-4 Proteoglycan in Human Rhabdomyosarcoma. | Int J Mol Sci | 2025 | 40076757 | PubTator, text mining | PubMed |
| Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines. | Signal Transduct Target Ther | 2025 | 40059188 | PubTator, text mining | PubMed |
| Evidence that the cell glycocalyx envelops respiratory syncytial virus (RSV) particles that form on the surface of RSV-infected human airway cells. | Virology | 2025 | 40044247 | PubTator, text mining | PubMed |
| AG73-GelMA/AlgMA hydrogels provide a stable microenvironment for the generation of pancreatic progenitor organoids. | J Nanobiotechnology | 2025 | 40016740 | PubTator, text mining | PubMed |
| TIMP2-mediated mitochondrial fragmentation and glycolytic reprogramming drive renal fibrogenesis following ischemia-reperfusion injury. | Free Radic Biol Med | 2025 | 39986488 | PubTator, text mining | PubMed |
| A Narrative Review: Syndecans in Aortic Aneurysm Pathogenesis and Course-Biomarkers and Targets? | Int J Mol Sci | 2025 | 39940978 | PubTator, text mining | PubMed |
| Role of syndecan-4 in angiogenesis and vasculogenic mimicry in triple negative breast cancer cells. | Matrix Biol | 2025 | 39938698 | PubTator, text mining | PubMed |
| Inhibition of EphA2 by syndecan-4 in wounded skin regulates clustering of fibroblasts. | J Mol Cell Biol | 2025 | 39716457 | PubTator, text mining | PubMed |
| MiR-629-5p May serve as a biomarker for pediatric acute respiratory distress syndrome and can regulate the inflammatory response. | Pediatr Neonatol | 2025 | 39277501 | PubTator, text mining | PubMed |
| Integration analysis of PLAUR as a sunitinib resistance and macrophage related biomarker in ccRCC, an in silicon and experimental study. | J Biomol Struct Dyn | 2025 | 38173169 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6385/papers?page=8